发明名称 Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl)thiazol-4-yl]-benzamide useful as cysteine protease inhibitor
摘要 There is provided Form 2 crystalline polymorph consisting of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazin-1-yl)thiazol-4-yl]-benzamide monohydrochloride and N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-b]pyrrole-4- carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazin-1-yl)thiazol-4-yl]-benzamide hydrate monohydrochloride, its use as a medicament and methods for its preparation.
申请公布号 AU2014307850(B8) 申请公布日期 2017.03.02
申请号 AU20140307850 申请日期 2014.08.13
申请人 Medivir AB 发明人 Grabowska, Urszula;Salvadore-Oden, Lourdes;Diaz Perez, Victor M.;Carr, Andrew
分类号 C07D491/048;A61K31/496;A61P19/00 主分类号 C07D491/048
代理机构 代理人
主权项
地址